Developing a new solution or establishing a viable and growing company requires funding. Investors, business partners, clinical partners… everybody expects the team and company to be fundable.
So, the question is: what should everyone in this industry understand about financing aspects? What kind of a team and start-up in health tech and life sciences is fundable? What kind of financing instruments exists? How do you build a financing portfolio for each stage of a lifecycle of a new company?
This webinar will be hosted by SPARK Finland.
Online via Zoom | Registerhereuntil January 11th
SPARK Europe is the joint network of SPARK sites all over Europe including Israel: SPARK-BIH, SPARK Finland, SPARK FLI, SPARK Poland and SPARK Tel Aviv. European SPARK programs are members of SPARK Global network. The purpose of SPARK programs is to provide the education and mentorship necessary to advance research discoveries from the bench to the bedside, hence to increase the maturity of academic and clinical discoveries towards practical solutions that address unmet needs in the life science and health tech space. The program follows the same principles that have been the cornerstones of SPARK at Stanford since it was established by Professor Daria Mochly-Rosen and Kevin Grimes in 2006 for advancing new biomedical research discoveries into promising new treatments for patients.
